<?xml version="1.0" encoding="UTF-8"?>
<results title="drug">
 <result pre="antiviral drugs such as oseltamivir, zanamivir, and baloxavir. Oseltamivir and" exact="zanamivir" post="are approved neuraminidase (NA) inhibitors (4). Using standard in"/>
 <result pre="vitro NA inhibition assays, we determined that both oseltamivir and" exact="zanamivir" post="potently inhibit the NA activity of WSN/33-Renilla IAV-like particles"/>
 <result pre="drug sensitivities similar to those of authentic IAVs. Oseltamivir and" exact="zanamivir" post="sensitivity of WSN/33 and WSN/33-Renilla IAV particles (A and"/>
 <result pre="in vitro NA inhibition assays revealed that both oseltamivir and" exact="zanamivir" post="inhibit the NA activity of Viet/04-T-Renilla IAV-like particles with"/>
 <result pre="reporter with gain-of-function HA amino acid substitutions. Oseltamivir carboxylate and" exact="zanamivir" post="sensitivity of Viet/04-Renilla and Viet/04-T-Renilla IAV particles (A and"/>
 <result pre="concentrations of oseltamivir carboxylate (no. sc-212484; Santa Cruz Biotechnology) or" exact="zanamivir" post="(no. SML0492; Sigma-Aldrich), and chemiluminescence was measured with the"/>
</results>
